Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR−/− and apoE−/− mice
Open Access
- 1 June 2009
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 50 (6), 1090-1100
- https://doi.org/10.1194/jlr.m800619-jlr200
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Loss of small heterodimer partner expression in the liver protects against dyslipidemiaJournal of Lipid Research, 2009
- Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesisProceedings of the National Academy of Sciences of the United States of America, 2007
- Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in WomenJAMA, 2007
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Effects of FXR in foam-cell formation and atherosclerosis developmentBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006
- Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR AgonistsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Estrogen Receptor α Regulates Expression of the Orphan Receptor Small Heterodimer PartnerPublished by Elsevier BV ,2003
- The Farnesoid X-receptor Is an Essential Regulator of Cholesterol HomeostasisJournal of Biological Chemistry, 2003
- Transgenic Expression of Cholesterol-7-α-Hydroxylase Prevents Atherosclerosis in C57BL/6J MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Adenovirus-mediated transfer of a gene encoding cholesterol 7 alpha-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol.JCI Insight, 1995